Phase III Non-Inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer
EClinicalMedicine - United Kingdom
doi 10.1016/j.eclinm.2019.03.011
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2019
Authors
Publisher
Elsevier BV